PROTECT-trial Consortium

The first Italian PROTECT patient has been treated with protons at the Trento Proton Therapy Centre. Read more on why Trento participates in the PROTECT study, protonterapia.provincia.tn.it/eng/News-and-e…

Read the paper here: medicaljournalssweden.se/actaoncologica…

The PROTECT RTQA paper has been published. View of Radiotherapy quality assurance in the PROTECT trial – a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

We're now on Bluesky! Follow us at @protect-trial.bsky.social for the latest updates on the PROTECT study.

The RTQA group visited USZ and PSI (Switzerland). Through the exchange of treatment experiences, these visits are of great value to the PROTECT study and the participating sites. All with the common goal of improving the treatment of esophageal cancer. (protecttrial.eu)

To read more about the RTQA work in the PROTECT study: protecttrial.eu/clinical-trial…

First of the yearly RTQA meetings in the PROTECT trial. Great success with a lot of fantastic contributions and discussions. More than 40 participants. Thank you for joining. Looking forward to continued collaboration.

The PROTECT protocol paper is now online. thegreenjournal.com/article/S0167-…

The Paul Scherrer Institute (@psich_de) and University Hospital Zurich(@Unispital_USZ) are now treating PROTECT patients in Switzerland. Read more at: psi.ch/en/media/our-r…. This marks the 25th patient in the PROTECT study.

First of many site visits completed. As a part of the PROTECT study all RT sites goes through an ambitions review program. AUH/DCPT had the pleasure of being quality assured by staff from @OncoRay_Press & @MAASTROclinic. Read more about WP3 QA at protecttrial.eu/currently/work…

Congratulations to @UZLeuven

PROTECT is now an active multicenter study, after the first patient has started treatment at the proton therapy center PARTICLE in UZ Leuven, BE. For more information visit: protecttrial.eu/display/artike…

The first of 396 patients has been enrolled into the PROTECT study with the aim of setting new standards for the clinical use of proton radiotherapy in esophageal cancer. For more information visit: protecttrial.eu/display/artike…

First PROTECT-trial publication: Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight european centres. doi.org/10.1016/j.rado…

Presentation, by Lone Hoffmann in #ESTRO2021. OC-0631 - Proton and photon treatment planning comparison for oesophageal cancer between six European centres. #aeprot #protontherapy #particletherapy #protonterapia #oesophagealcancer @PROTECT_trial

Lone Hoffmann presents (some of) the extensive pre-trial RTQA work for @PROTECT_trial. Getting 8 international proton centres to produce comparable & robust PT (and XRT!) plans is not straightforward. And, perhaps counterintuitively, XRT plans are overall less robust #ESTRO2021

Hear Lone Hoffmann present the PROTECT study protocol at #ESTRO2021: Proton and photon treatment planning comparison for oesophageal cancer between six European centres. Monday 30th Aug. 16.45-16.55 (CET) Presentation Number: OC-0631

Hear @VarianMedSys @ibaworldwide & @CaiGrau's take on the potentials of the PROTECT-trial partnership and the joint ambitions to develop the clinical use of #ProtonTherapy. For more information visit protect-trial.eu

19 partners join forces in European public-private partnership backed by @IMI_JU, @VarianMedSys and @ibaworldwide to gather clinical evidence within #ProtonTherapy for #EsophagealCancer. Full press release on PROTECT-trial launch at #news-20606" target="_blank" rel="nofollow noopener">protecttrial.eu/news/#news-206… #RadioTherapy #RadOnc